This site contains promotional content intended for UK Healthcare Professionals and other relevant decision makers | Not a HCP? Visit our Public Site.
Adverse Event reporting can be found at the bottom of the page | Prescribing Information for the relevant medicine can be found adjacent to the below content and/or in the footer below.

Mirena® (52mg levonorgestrel) in Perimenopausal and Postmenopausal Women

Learn about Mirena's licensed indications, its efficacy and continuation data in perimenopausal and postmenopausal women, prescribing considerations and how it may fit with a woman's needs, preferences and lifestyle.

Mirena in perimenopausal and postmenopausal women by Dr Diana Mansour (6 mins)

Mirena® (52mg levonorgestrel) Prescribing Information

Speakers

Dr Diana Mansour

Dr Diana Mansour
Consultant Community Gynaecologist, Newcastle upon Tyne

Defining the Menopause

(6 mins) Discover how we define menopause, when and why it occurs, the different types and stages, and the symptoms.

Mirena® (52mg levonorgestrel) Prescribing Information

PP-PF-WHC-IUS-GB-0124, October 2026

Diagnosing the Menopause

(4 mins) How to diagnose and help menopausal women to find an approach that works for them.

Mirena® (52mg levonorgestrel) Prescribing Information

PP-PF-WHC-IUS-GB-0125, October 2026

Menopause, Perimenopause and Endometrial Protection

Learn more about the Menopause.

PP-PF-WHC-IUS-GB-0127, October 2026

PP-PF-WHC-IUS-GB-0126 | October 2026